Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and

Paula M Keeney1, Jing Xie, Roderick A Capaldi

  • 1Center for the Study of Neurodegenerative Diseases, University of Virginia, Charlottesville, Virginia 22908, USA.

Insights

Parkinson's disease (PD) involves mitochondrial complex I dysfunction. This study found that PD brain complex I shows increased oxidation and misassembly, suggesting internal auto-oxidation rather than external oxidative stress contributes to neurodegeneration.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Biochemistry

Background:

  • Mitochondrial complex I (CI) dysfunction is implicated in sporadic Parkinson's disease (PD).
  • CI catalytic activity loss is observed in PD tissues and by PD-associated neurotoxins.

Purpose of the Study:

  • To quantify electron transport chain (ETC) proteins and complex I subunit oxidation in PD brain mitochondria.
  • To investigate the relationship between CI function, protein oxidation, and subunit levels in PD.

Main Methods:

  • Utilized subunit-specific antibodies for immunocapture of the entire complex I macroassembly.
  • Quantified ETC proteins and protein oxidation (carbonyls) in mitochondria from PD and control brains.
  • Measured NADH-driven electron transfer rates and correlated them with oxidation and subunit levels.

Main Results:

  • PD brain CI exhibited increased ND6 (11%), decreased 8 kDa subunit (34%), and 47% more protein carbonyls on catalytic subunits.
  • No significant changes were found in ETC complexes II-V protein levels.
  • CI function inversely correlated with protein oxidation and positively with 8 kDa subunit reduction.

Conclusions:

  • Reduced CI function in PD brains stems from internal auto-oxidation of catalytic subunits, not external oxidative stress.
  • CI misassembly correlates with this auto-oxidation, potentially due to genetic factors or toxins.
  • Findings suggest internal mitochondrial processes contribute to PD pathogenesis.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...